Showing results (381-390 of 503) with videos related to
Sort By:
Pageof 51
European Journal of Clinical Investigation|April 9, 2005
Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?S Bo, R Gambino, B Uberti, et al.Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
Telomere dysfunction alters the chemotherapeutic profile of transformed cellsK H Lee, K L Rudolph, Y J Ju, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 14, 1998
Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenylJ S Wadia, R M Chalmers-Redman, W J Ju, et al.Journal of the American College of Surgeons|May 8, 2007
Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E overexpressionKerry W Byrnes, Arrigo DeBenedetti, Neal T Holm, et al.Environmental Science & Technology|July 14, 2007
Mathematical model developed for environmental samples: prediction of GC/MS dioxin TEQ from XDS-CALUX bioassay dataDavid J Brown, Jean Orelien, John D Gordon, et al.Pediatric Radiology|March 29, 2019
Early proton magnetic resonance spectroscopy during and after therapeutic hypothermia in perinatal hypoxic-ischemic encephalopathyAshley M Lucke, Anil N Shetty, Joseph L Hagan, et al.The Journal of Clinical Investigation|March 15, 2008
IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in miceDonna L Thibault, Alvina D Chu, Kareem L Graham, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 8, 2017
Self-reported adherence to diet and preferences towards type of meal plan in patient with type 2 diabetes mellitus. A cross-sectional studyV Ponzo, R Rosato, E Tarsia, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 17, 2008
Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markersS Bo, G Ciccone, I Baldi, et al.Pharmacological Research|August 14, 2016
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trialS Bo, V Ponzo, G Ciccone, et al.Pageof 51